FDA
-
-
-
-
-
-
-
TME Pharma Provides Results of Final Exercise of Warrants Z
-
-
-
-
-
-
-
TME Pharma Announces New Strategy
-
-
-
-
-
-
-
TME Pharma: Half-yearly Report on the Liquidity Contract With Invest Securities
-
-
-
-
-
-
-
TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer
-
-
-
-
-
-
-
TME Pharma Provides Update on Resources Allocated to the Liquidity Contract With Invest Securities
-
-
-
-
-
-
-
TME Pharma Announces a Financing Guarantee Agreement and the Launch of Capital Increase of Minimum 2.2 Million Euros
-
-
-
-
-
-
-
TME Pharma Announces the End of the Convertible Debt Program With the Successful €1.48 Million Financing Intended for Buyback of All Outstanding Convertible Debt
-
324,035 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

